|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000122970 |
Summary for IFT81 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000122970 | Gene symbol | IFT81 |
| Gene name | intraflagellar transport 81 | |
| HGNC | 14313 | |
| Entrez ID | 28981 | |
| Gene type | protein_coding | |
| Synonyms | IFT81|CDV-1R|MGC4027 | |
| UniProtAcc | Q8WYA0 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for IFT81 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| IFT81 | 5.27e+02 | 1.18e+00 | 2.56e-01 | 4.61e+00 | 3.95e-06 | 2.48e-05 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for IFT81 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for IFT81 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg11930390 | chr12:110124004 | CGI:chr12:110124333-110124895 | promoter | 3.87e-01 | 2.76e-01 | 3.36e+00 | 7.86e-04 | 1.26e-03 | 1.10e-01 |
| BLCA | cg03204177 | chr12:110123150 | CGI:chr12:110124333-110124895 | promoter | 7.54e-01 | 9.07e-01 | -2.96e+00 | 3.04e-03 | 5.47e-03 | -1.53e-01 |
| BLCA | cg11930390 | chr12:110124004 | CGI:chr12:110124333-110124895 | promoter | 3.40e-01 | 5.23e-01 | -2.20e+00 | 2.76e-02 | 3.15e-02 | -1.84e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg03698892 | chr12:110124049 | CGI:chr12:110124333-110124895 | promoter | 9.04e-02 | 1.98e-01 | -3.52e+00 | 4.31e-04 | 3.45e-03 | -1.07e-01 |
Top |
Exon skipping events with PSI in TCGA for IFT81 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for IFT81 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for IFT81 |
| TFs related to IFT81. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| DLBC | PRDM6 | IFT81 | 3.11e+00 | 6.28e-03 | 4.12e+00 | 9.81e-01 | Female-biased |
| DLBC | ZNF225 | IFT81 | 3.36e+00 | 9.00e-03 | 4.28e+00 | 9.81e-01 | Female-biased |
| DLBC | ZNF235 | IFT81 | 3.21e+00 | 2.87e-03 | 4.45e+00 | 9.90e-01 | Female-biased |
| DLBC | ZNF287 | IFT81 | 3.19e+00 | 3.49e-03 | 4.37e+00 | 9.88e-01 | Female-biased |
| DLBC | ZNF487 | IFT81 | 3.29e+00 | 5.55e-03 | 4.35e+00 | 9.86e-01 | Female-biased |
| DLBC | ZNF879 | IFT81 | 3.80e+00 | 1.42e-02 | 4.60e+00 | 9.80e-01 | Female-biased |
| LAML | DLX3 | IFT81 | 4.82e+00 | 9.87e-01 | 3.82e+00 | 7.27e-03 | Male-biased |
| LAML | DMRT2 | IFT81 | 4.69e+00 | 9.92e-01 | 3.34e+00 | 1.92e-03 | Male-biased |
| LAML | DUX4 | IFT81 | 4.72e+00 | 9.83e-01 | 3.82e+00 | 1.04e-02 | Male-biased |
| LAML | DUXA | IFT81 | 4.72e+00 | 9.88e-01 | 3.65e+00 | 5.63e-03 | Male-biased |
| LAML | FOXA1 | IFT81 | 4.17e+00 | 9.85e-01 | 2.62e+00 | 8.24e-04 | Male-biased |
| LAML | FOXA3 | IFT81 | 4.26e+00 | 9.87e-01 | 2.72e+00 | 8.65e-04 | Male-biased |
| LAML | FOXB1 | IFT81 | 4.43e+00 | 9.89e-01 | 2.86e+00 | 7.79e-04 | Male-biased |
| LAML | FOXD3 | IFT81 | 4.23e+00 | 9.86e-01 | 2.75e+00 | 1.09e-03 | Male-biased |
| LAML | FOXR2 | IFT81 | 4.25e+00 | 9.86e-01 | 2.66e+00 | 7.17e-04 | Male-biased |
| LAML | HSF5 | IFT81 | 4.89e+00 | 9.87e-01 | 3.93e+00 | 8.52e-03 | Male-biased |
| LAML | IRX5 | IFT81 | 5.47e+00 | 9.86e-01 | 4.60e+00 | 1.18e-02 | Male-biased |
| LAML | MEIS1 | IFT81 | 4.45e+00 | 9.85e-01 | 3.36e+00 | 5.08e-03 | Male-biased |
| LAML | NKX6-1 | IFT81 | 4.20e+00 | 9.84e-01 | 2.82e+00 | 1.68e-03 | Male-biased |
| LAML | POU4F1 | IFT81 | 4.35e+00 | 9.86e-01 | 3.11e+00 | 2.86e-03 | Male-biased |
| LAML | POU4F2 | IFT81 | 4.31e+00 | 9.86e-01 | 2.95e+00 | 1.82e-03 | Male-biased |
| LAML | SOX21 | IFT81 | 4.38e+00 | 9.86e-01 | 3.17e+00 | 3.22e-03 | Male-biased |
| LAML | SOX7 | IFT81 | 4.29e+00 | 9.85e-01 | 3.08e+00 | 3.19e-03 | Male-biased |
| LAML | SRF | IFT81 | 4.29e+00 | 9.83e-01 | 3.18e+00 | 4.64e-03 | Male-biased |
| LAML | TLX3 | IFT81 | 5.55e+00 | 9.91e-01 | 4.56e+00 | 7.59e-03 | Male-biased |
| LAML | ZNF250 | IFT81 | 4.26e+00 | 9.83e-01 | 3.13e+00 | 4.30e-03 | Male-biased |
| LAML | ZNF418 | IFT81 | 4.58e+00 | 9.92e-01 | 2.89e+00 | 4.60e-04 | Male-biased |
| LAML | ZNF653 | IFT81 | 5.25e+00 | 9.83e-01 | 4.43e+00 | 1.45e-02 | Male-biased |
| LAML | ZNF79 | IFT81 | 4.28e+00 | 9.87e-01 | 2.74e+00 | 8.55e-04 | Male-biased |
| LGG | ZNF418 | IFT81 | 3.88e+00 | 5.39e-03 | 4.49e+00 | 9.87e-01 | Female-biased |
| MESO | DMRT2 | IFT81 | 3.75e+00 | 1.39e-02 | 4.93e+00 | 9.82e-01 | Female-biased |
| MESO | FOXA1 | IFT81 | 3.31e+00 | 7.19e-03 | 4.69e+00 | 9.87e-01 | Female-biased |
| MESO | FOXA3 | IFT81 | 3.43e+00 | 9.25e-03 | 4.73e+00 | 9.86e-01 | Female-biased |
| MESO | FOXB1 | IFT81 | 3.46e+00 | 1.05e-02 | 4.72e+00 | 9.84e-01 | Female-biased |
| MESO | FOXD3 | IFT81 | 3.35e+00 | 1.07e-02 | 4.60e+00 | 9.83e-01 | Female-biased |
| MESO | FOXR2 | IFT81 | 3.19e+00 | 6.54e-03 | 4.60e+00 | 9.87e-01 | Female-biased |
| MESO | NKX6-1 | IFT81 | 3.32e+00 | 9.03e-03 | 4.63e+00 | 9.85e-01 | Female-biased |
| MESO | ZNF418 | IFT81 | 3.06e+00 | 2.13e-03 | 4.79e+00 | 9.93e-01 | Female-biased |
| MESO | ZNF79 | IFT81 | 3.22e+00 | 5.45e-03 | 4.68e+00 | 9.89e-01 | Female-biased |
| PAAD | DMRT2 | IFT81 | 4.48e+00 | 9.82e-01 | 3.66e+00 | 1.04e-02 | Male-biased |
| PAAD | FOXA1 | IFT81 | 4.02e+00 | 9.82e-01 | 3.02e+00 | 4.01e-03 | Male-biased |
| PAAD | FOXA3 | IFT81 | 4.06e+00 | 9.82e-01 | 3.05e+00 | 4.02e-03 | Male-biased |
| PAAD | FOXB1 | IFT81 | 4.16e+00 | 9.83e-01 | 3.21e+00 | 5.48e-03 | Male-biased |
| PAAD | FOXR2 | IFT81 | 4.06e+00 | 9.84e-01 | 2.99e+00 | 2.75e-03 | Male-biased |
| PAAD | NKX6-1 | IFT81 | 4.03e+00 | 9.82e-01 | 3.02e+00 | 3.89e-03 | Male-biased |
| PAAD | POU4F2 | IFT81 | 4.08e+00 | 9.82e-01 | 3.14e+00 | 5.37e-03 | Male-biased |
| PAAD | SOX7 | IFT81 | 4.25e+00 | 9.81e-01 | 3.39e+00 | 8.69e-03 | Male-biased |
| PAAD | ZNF418 | IFT81 | 4.68e+00 | 9.94e-01 | 3.32e+00 | 6.73e-04 | Male-biased |
| PAAD | ZNF79 | IFT81 | 4.29e+00 | 9.89e-01 | 3.15e+00 | 2.04e-03 | Male-biased |
| PAAD | ZNF879 | IFT81 | 4.36e+00 | 9.83e-01 | 3.51e+00 | 8.79e-03 | Male-biased |
| IFT81 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for IFT81 |
| RBPs related to ES in IFT81. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | ZNF638 | exon_skip_86879 | 1.31e+01 | 9.97e-01 | 1.24e+01 | 2.66e-03 | Male-biased |
| THYM | KHDRBS1 | exon_skip_86881 | 9.03e+00 | 9.92e-01 | 8.61e+00 | 3.62e-03 | Male-biased |
| LUAD | ZNF638 | exon_skip_86879 | 1.30e+01 | 9.97e-01 | 1.26e+01 | 2.95e-03 | Male-biased |
| BRCA | ZNF638 | exon_skip_86879 | 1.30e+01 | 9.92e-01 | 1.24e+01 | 7.87e-03 | Male-biased |
| ESCA | KHDRBS1 | exon_skip_86881 | 8.33e+00 | 1.35e-02 | 8.73e+00 | 9.81e-01 | Female-biased |
| READ | ZNF638 | exon_skip_86879 | 1.30e+01 | 9.96e-01 | 1.26e+01 | 3.76e-03 | Male-biased |
| PCPG | U2AF2 | exon_skip_86881 | 7.27e+00 | 4.00e-03 | 7.67e+00 | 9.86e-01 | Female-biased |
| LGG | ZNF638 | exon_skip_86879 | 1.31e+01 | 9.98e-01 | 1.26e+01 | 1.76e-03 | Male-biased |
| GBM | KHDRBS1 | exon_skip_86881 | 8.86e+00 | 9.88e-01 | 8.50e+00 | 7.41e-03 | Male-biased |
| GBM | ZNF638 | exon_skip_86879 | 1.25e+01 | 6.06e-04 | 1.31e+01 | 9.99e-01 | Female-biased |
| PAAD | SART3 | exon_skip_86879 | 6.99e+00 | 9.83e-01 | 6.61e+00 | 3.28e-03 | Male-biased |
| PAAD | ZNF638 | exon_skip_86879 | 1.29e+01 | 9.98e-01 | 1.24e+01 | 1.28e-03 | Male-biased |
| IFT81 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1344862 | chr12:115894012:G:A | - | 0.0344495540179763 | 0.0483395724629583 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11112204 | chr12:104824133:C:T | - | 0.10145897892591 | 0.0283262582532852 | LUSC | Male-baised eQTL |
| rs754724 | chr12:106109696:T:C | - | 0.0506168436416153 | 0.0114438990132983 | KIRC | Male-baised eQTL |
| rs10746055 | chr12:106108307:G:A | - | 0.050200140775514 | 0.018692777088377 | KIRC | Male-baised eQTL |
| rs2569973 | chr12:106097978:A:G | - | 0.0497974029174882 | 0.0193888612505381 | KIRC | Male-baised eQTL |
| rs7131912 | chr12:106103169:C:G | - | 0.049100354234105 | 0.0254271063475027 | KIRC | Male-baised eQTL |
| rs967872 | chr12:106098517:T:C | - | 0.0462164226927448 | 0.0275038336275237 | KIRC | Male-baised eQTL |
| rs7311554 | chr12:103783979:G:C | - | 0.096472133284646 | 0.0339372939613321 | KIRC | Male-baised eQTL |
| rs71468272 | chr12:105635936:A:G | - | 0.0629600130294092 | 0.0377948840171266 | KIRC | Male-baised eQTL |
| rs2629745 | chr12:104110028:A:G | - | 0.0742908715127551 | 0.0455956271611319 | KIRC | Male-baised eQTL |
| rs11112872 | chr12:106111556:T:G | - | 0.0501823328877518 | 0.0490744325486445 | KIRC | Male-baised eQTL |
| rs2888860 | chr12:105635011:G:A | - | 0.0613138763840884 | 0.0492006255037564 | KIRC | Male-baised eQTL |
| rs2436597 | chr12:106091807:A:C | - | 0.0464348028742599 | 0.049345502994278 | KIRC | Male-baised eQTL |
| rs10507262 | chr12:115471783:G:A | - | 0.0649227024156736 | 0.0108433934498148 | BLCA | Male-baised eQTL |
| rs10507274 | chr12:116723171:T:C | - | 0.126021413483629 | 0.000604229851676553 | COAD | Male-baised eQTL |
| rs76428245 | chr12:113571888:C:T | - | 0.149702848393415 | 0.00113164767889933 | COAD | Male-baised eQTL |
| rs73201031 | chr12:113566801:C:T | - | 0.12734440071327 | 0.00140208623609049 | COAD | Male-baised eQTL |
| rs144040101 | chr12:113556979:C:T | - | 0.126959420153218 | 0.00147321910976871 | COAD | Male-baised eQTL |
| rs73201020 | chr12:113557057:C:T | - | 0.126959420153218 | 0.00147321910976871 | COAD | Male-baised eQTL |
| rs78431182 | chr12:113559877:T:G | - | 0.126959420153218 | 0.00147321910976871 | COAD | Male-baised eQTL |
| rs73201024 | chr12:113560609:C:T | - | 0.126959420153218 | 0.00147321910976871 | COAD | Male-baised eQTL |
| rs7961685 | chr12:108120524:T:A | - | 0.0680263903653945 | 0.00222137403997681 | COAD | Male-baised eQTL |
| rs116014361 | chr12:119284330:A:T | - | 0.143580502772258 | 0.00242350493047571 | COAD | Male-baised eQTL |
| rs7295769 | chr12:113723530:A:C | - | 0.0675242757062761 | 0.00285164285186383 | COAD | Male-baised eQTL |
| rs111767297 | chr12:113566469:C:T | - | 0.114387544193544 | 0.00316481621752619 | COAD | Male-baised eQTL |
| rs7971387 | chr12:115936605:T:G | - | 0.117348512163608 | 0.00355060128628036 | COAD | Male-baised eQTL |
| rs77326849 | chr12:108458907:G:A | - | 0.146485311166277 | 0.00529267163941359 | COAD | Male-baised eQTL |
| rs77635192 | chr12:108407411:A:G | - | 0.146603552458924 | 0.00532704877523606 | COAD | Male-baised eQTL |
| rs78851973 | chr12:108410837:G:A | - | 0.146444432052635 | 0.0053943738350126 | COAD | Male-baised eQTL |
| rs6490232 | chr12:119061768:A:T | - | -0.0594712803386459 | 0.00570227252501721 | COAD | Male-baised eQTL |
| rs112302457 | chr12:108451296:C:A | - | 0.14557276112067 | 0.00577552758636137 | COAD | Male-baised eQTL |
| rs12422410 | chr12:115901491:G:A | - | 0.125456771473481 | 0.00627592591834846 | COAD | Male-baised eQTL |
| rs78977547 | chr12:115903798:T:A | - | 0.125456771473481 | 0.00627592591834846 | COAD | Male-baised eQTL |
| rs12425597 | chr12:115904344:T:A | - | 0.125456771473481 | 0.00627592591834846 | COAD | Male-baised eQTL |
| rs17722146 | chr12:115898512:C:T | - | 0.12320558863987 | 0.00797842234000952 | COAD | Male-baised eQTL |
| rs11066619 | chr12:113592593:G:A | - | 0.0870066039029866 | 0.0122679834398763 | COAD | Male-baised eQTL |
| rs73201056 | chr12:113594895:A:T | - | 0.0870066039029866 | 0.0122679834398763 | COAD | Male-baised eQTL |
| rs112164429 | chr12:113595917:C:T | - | 0.0870066039029866 | 0.0122679834398763 | COAD | Male-baised eQTL |
| rs11066623 | chr12:113597063:G:A | - | 0.0870066039029866 | 0.0122679834398763 | COAD | Male-baised eQTL |
| rs12229199 | chr12:113603019:A:T | - | 0.0859649522712817 | 0.0125333069314949 | COAD | Male-baised eQTL |
| rs11066638 | chr12:113609770:T:C | - | 0.0859754308510054 | 0.0142859700163663 | COAD | Male-baised eQTL |
| rs11066626 | chr12:113598993:C:G | - | 0.0850908557007979 | 0.0151344066808181 | COAD | Male-baised eQTL |
| rs73201060 | chr12:113601375:G:A | - | 0.0850908557007979 | 0.0151344066808181 | COAD | Male-baised eQTL |
| rs10507240 | chr12:113602864:G:A | - | 0.0847057030693724 | 0.0158633692700391 | COAD | Male-baised eQTL |
| rs73201065 | chr12:113605447:G:A | - | 0.0831729387310012 | 0.0178188819492635 | COAD | Male-baised eQTL |
| rs12230637 | chr12:104865098:G:A | - | 0.102137848862718 | 0.0266656796196932 | COAD | Male-baised eQTL |
| rs11835327 | chr12:114432192:A:G | - | 0.0784329720056814 | 0.0282858356537521 | COAD | Male-baised eQTL |
| rs16944251 | chr12:114432565:T:A | - | 0.0895555801564906 | 0.0291971849954071 | COAD | Male-baised eQTL |
| rs1845678 | chr12:102662751:C:G | - | 0.0545229300377318 | 0.0292781435493541 | COAD | Male-baised eQTL |
| rs1846389 | chr12:102664619:C:T | - | 0.0545229300377318 | 0.0292781435493541 | COAD | Male-baised eQTL |
| rs11066610 | chr12:113573184:A:G | - | 0.0859753277931194 | 0.0329608032433863 | COAD | Male-baised eQTL |
| rs2434081 | chr12:106134676:C:T | - | -0.0515225090093276 | 0.0346052265405044 | COAD | Male-baised eQTL |
| rs2453512 | chr12:102664064:C:T | - | 0.0535585166131179 | 0.0355010414181037 | COAD | Male-baised eQTL |
| rs17030542 | chr12:100756289:G:A | - | 0.0827307379526274 | 0.0355121081860092 | COAD | Male-baised eQTL |
| rs7966478 | chr12:119939588:G:A | - | 0.0497608381620165 | 0.0361173709727441 | COAD | Male-baised eQTL |
| rs2551394 | chr12:114381955:A:G | - | -0.0566847106571598 | 0.0404853260839068 | COAD | Male-baised eQTL |
| rs79752171 | chr12:115736499:C:T | - | 0.122823858261615 | 0.040850861843529 | COAD | Male-baised eQTL |
| rs2243653 | chr12:114552936:C:T | - | -0.0535173712255208 | 0.0432702895884988 | COAD | Male-baised eQTL |
| rs2555027 | chr12:114382475:G:A | - | -0.0563176921113521 | 0.0435050114409861 | COAD | Male-baised eQTL |
| rs857749 | chr12:114555969:C:T | - | -0.0532270851946048 | 0.0438939579188895 | COAD | Male-baised eQTL |
| rs804709 | chr12:119814992:C:T | - | 0.0513047614455273 | 0.0465522027966424 | COAD | Male-baised eQTL |
| rs73201051 | chr12:113585662:C:T | - | 0.084469369342065 | 0.0477288482746349 | COAD | Male-baised eQTL |
| rs73201052 | chr12:113585708:G:C | - | 0.084469369342065 | 0.0477288482746349 | COAD | Male-baised eQTL |
| rs430998 | chr12:119815854:G:A | - | 0.0513825581865212 | 0.0478245991427084 | COAD | Male-baised eQTL |
| rs613778 | chr12:101068261:A:G | - | 0.0555578332799313 | 0.0480083093567642 | COAD | Male-baised eQTL |
| rs7306306 | chr12:115096070:C:T | - | 0.0747608791007655 | 0.0481990212115827 | COAD | Male-baised eQTL |
| rs2649712 | chr12:106195880:C:G | - | 0.0536548386804713 | 0.0492494441739652 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_86867 | chr12:110143381:110143545 | Frame-shift | rs73194272 | chr12:109452837:T:C | Distant upstream | -0.0318426748940361 | 0.0367352772321036 | LUAD | Male-baised sQTL |
| exon_skip_86867 | chr12:110143381:110143545 | Frame-shift | rs7298925 | chr12:109486901:C:T | Distant upstream | -0.0669089044241233 | 0.0246497460583346 | THCA | Male-baised sQTL |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of IFT81 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
